What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
His main research concerns Internal medicine, Immunology, Gastroenterology, Hepatitis C virus and Hepatitis C.
His Internal medicine study incorporates themes from Coinfection, Efavirenz and Nevirapine.
His research ties Acquired immunodeficiency syndrome and Immunology together.
His work carried out in the field of Acquired immunodeficiency syndrome brings together such families of science as Logistic regression, Malignancy, T cell, Circulating MicroRNA and Case-control study.
His Hepatitis C virus research incorporates themes from Odds ratio and Viral disease.
His biological study spans a wide range of topics, including Viral hepatitis and Immunopathology.
His most cited work include:
- Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
- Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study. (253 citations)
- Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. (237 citations)
What are the main themes of his work throughout his whole career to date?
Luz Martín-Carbonero focuses on Internal medicine, Immunology, Gastroenterology, Virology and Hepatitis C virus.
His studies in Internal medicine integrate themes in fields like Coinfection and Ribavirin.
His research is interdisciplinary, bridging the disciplines of Acquired immunodeficiency syndrome and Immunology.
Luz Martín-Carbonero usually deals with Gastroenterology and limits it to topics linked to Atazanavir and Pharmacology.
When carried out as part of a general Virology research project, his work on Lamivudine, Viral load, Hepatitis B virus and Virological response is frequently linked to work in Drug resistance, therefore connecting diverse disciplines of study.
His Hepatitis C virus research includes themes of Interferon, Adverse effect, Pediatrics and Alanine transaminase.
He most often published in these fields:
- Internal medicine (58.67%)
- Immunology (46.00%)
- Gastroenterology (32.67%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (58.67%)
- Virology (32.00%)
- Hepatitis C (26.67%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Virology, Hepatitis C, Lamivudine and Immunology.
His Internal medicine study combines topics in areas such as Gastroenterology, Viral suppression and Viral load.
His work in the fields of Hepatitis and Hepatitis C virus overlaps with other areas such as Chemistry and Exosome.
His Hepatitis C research integrates issues from Psychiatry, Psychopathology, Depression, Anxiety and Virological response.
Luz Martín-Carbonero has included themes like Dolutegravir, Resistance mutation, Discontinuation and Cohort in his Lamivudine study.
His research links Malignancy with Immunology.
Between 2014 and 2021, his most popular works were:
- Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
- Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection. (22 citations)
- Impact of Nucleos(t)ide Reverse Transcriptase Inhibitors on Blood Telomere Length Changes in a Prospective Cohort of Aviremic HIV-Infected Adults. (10 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
His primary areas of study are Internal medicine, Immunology, Lamivudine, Telomerase and Viral load.
He interconnects Ribavirin and Hepatitis C virus in the investigation of issues within Internal medicine.
His Immunology study frequently links to other fields, such as Malignancy.
His work carried out in the field of Lamivudine brings together such families of science as Clinical trial, Discontinuation, Dolutegravir, Integrase inhibitor and Resistance mutation.
Luz Martín-Carbonero combines subjects such as Reverse-transcriptase inhibitor, Prospective cohort study, Cohort and Abacavir with his study of Viral load.
His studies deal with areas such as Reverse transcriptase and Confounding as well as Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
